433. How Are Psychedelics and Other Party Dru...

Podcasting started as a niche-nerd pursuit. Now it’s a $9 billion industry. Is that a lot? The strange economics of this thing we do. SOURCES:Jim Bankoff, chairman and C.E.O. of Vox Media.Ben Davis, head of digital at WME.Will Page, former chief economist at Spotify and author of ...  Show more

An economist calls America’s beef industry a “miracle.” An antitrust scholar calls it “broken.” Maybe they’re both right? SOURCES:Austin Frerick, agriculture antitrust expert, fellow at Yale University, author of Barons: Money, Power, and the Corruption of America's Food Industry ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic ...

Hallucinogenic drugs are currently illegal, but they were once commonly used in psychological treatment. In this episode, Josh and Chuck discuss the rise and fall of psychedelics in treating mood disorders -- and why they're starting to gain favor again.